Tsutomu Yamazaki Selected Research

Tsutomu Yamazaki Research Topics

Disease

24	Hypertension (High Blood Pressure) 01/2019 - 09/2003
22	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 07/2003
13	Atherosclerosis 06/2017 - 12/2008
12	Hemorrhage 04/2023 - 09/2003
11	Type 2 Diabetes Mellitus (MODY) 11/2023 - 10/2003
11	Venous Thromboembolism 09/2023 - 01/2018
11	Hypercholesterolemia 01/2018 - 04/2008
9	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 01/2018
9	Pulmonary Embolism 09/2023 - 01/2018
9	Myocardial Infarction 01/2019 - 09/2002
7	Diabetes Mellitus 01/2023 - 10/2006
6	Neoplasms (Cancer) 08/2023 - 04/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2008
6	Dyslipidemias (Dyslipidemia) 01/2019 - 03/2010
5	Pneumonia (Pneumonitis) 03/2023 - 01/2005
5	Atrial Fibrillation 01/2023 - 09/2003
5	Stroke (Strokes) 01/2019 - 01/2011
5	Heart Failure 04/2013 - 09/2003
4	Ischemic Stroke 01/2023 - 01/2011
4	Acute Coronary Syndrome 01/2023 - 10/2008
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 09/2009
4	Infections 08/2013 - 02/2006
3	Obesity 10/2016 - 07/2007
3	Vascular Diseases (Vascular Disease) 06/2013 - 01/2009
3	Hypertrophy 03/2011 - 10/2003
2	Wounds and Injuries (Trauma) 01/2024 - 04/2004
2	Insulin Resistance 09/2023 - 10/2003
2	Thromboembolism 01/2023 - 03/2022
2	Body Weight (Weight, Body) 01/2022 - 09/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2019 - 01/2016
2	Hemorrhagic Stroke 01/2019 - 12/2016
2	Thrombosis (Thrombus) 04/2018 - 06/2013
2	Left Ventricular Dysfunction 10/2016 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 08/2016 - 02/2012
2	Transient Ischemic Attack 01/2016 - 12/2014
2	Fever (Fevers) 01/2016 - 02/2006
2	Bronchitis 05/2015 - 04/2008
2	Cerebral Infarction 01/2014 - 09/2003
2	Carotid Artery Diseases 01/2014 - 01/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 04/2008 - 06/2006
2	Meningitis 04/2006 - 01/2003
2	Cardiomegaly (Heart Hypertrophy) 09/2004 - 01/2002
2	Proteinuria 01/2004 - 09/2003
2	Chronic Renal Insufficiency 01/2004 - 09/2003
1	Shock 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023
1	COVID-19 03/2023

Drug/Important Bio-Agent (IBA)

15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 12/2007
12	RivaroxabanIBA 08/2023 - 01/2018
12	LipidsIBA 01/2022 - 12/2008
11	oxidized low density lipoproteinIBA 01/2022 - 04/2008
10	LDL CholesterolIBA 11/2023 - 04/2008
9	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2011 - 09/2002
8	Amlodipine (Norvasc)FDA LinkGeneric 01/2012 - 09/2003
7	AnticoagulantsIBA 09/2023 - 01/2018
7	Rosuvastatin Calcium (Crestor)FDA Link 01/2014 - 12/2008
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2019 - 03/2010
6	Angiotensin Receptor AntagonistsIBA 02/2012 - 09/2003
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2012
5	Antihypertensive Agents (Antihypertensives)IBA 06/2013 - 09/2003
4	Uric Acid (Urate)IBA 12/2018 - 05/2009
4	CholesterolIBA 10/2016 - 07/2007
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2013 - 01/2009
4	Losartan (Cozaar)FDA LinkGeneric 03/2011 - 09/2003
3	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 04/2018 - 12/2014
3	CreatinineIBA 10/2016 - 09/2003
3	AntigensIBA 05/2015 - 01/2003
3	candesartanIBA 04/2011 - 09/2006
3	Proteins (Proteins, Gene)FDA Link 04/2008 - 09/2003
2	Triglycerides (Triacylglycerol)IBA 11/2023 - 09/2009
2	CytokinesIBA 09/2023 - 11/2009
2	Insulin (Novolin)FDA Link 09/2023 - 12/2009
2	vinyltriethoxysilane (VTES)IBA 03/2022 - 01/2022
2	alogliptinIBA 01/2021 - 09/2014
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 10/2016
2	MacrolidesIBA 01/2016 - 02/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 04/2006
2	Pioglitazone (Actos)FDA Link 01/2014 - 12/2009
2	DiureticsIBA 06/2013 - 09/2003
2	Valsartan (Vals)FDA Link 02/2013 - 09/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2012 - 10/2006
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2011 - 10/2006
2	C-Reactive ProteinIBA 09/2009 - 01/2009
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2009 - 01/2002
2	Atorvastatin (Lipitor)FDA Link 01/2009 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 04/2008 - 03/2005
2	Angiotensin IIIBA 10/2006 - 09/2004
2	Atrial Natriuretic Factor (ANF)IBA 09/2004 - 01/2002
1	CarbohydratesIBA 09/2023
1	MonosaccharidesIBA 09/2023
1	SteroidsIBA 03/2023
1	FibrinIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023

Therapy/Procedure

26	Therapeutics 03/2023 - 09/2003
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2014 - 03/2006
2	Secondary Prevention 01/2014 - 04/2010
2	Glycemic Control 12/2009 - 10/2006
1	Thoracotomy 01/2024
1	Vena Cava Filters (Inferior Vena Cava Filter) 09/2023
1	Duration of Therapy 04/2023